Chimera Researc...'s  Instablog

Chimera Research Group
Send Message
The founding members of Chimera Research Group have over 50 years of combined experience in the biotech and pharmaceutical sector. Their experience includes work at Investment Banks, Hedge Funds, Pharmaceutical Companies, top-tier Universities, and the U.S. Food and Drug Administration (FDA).... More
My company:
Chimera Research Group
My blog:
Chimera Blog
My book:
The Biotech Trader Handbook (2nd Edition)
  • APPY Options Appear Mispriced into Results 2 comments
    Apr 11, 2010 10:43 PM | about stocks: APPY
    APPY is slated to report top-line results for AppyScore by mid-May.  Based on a quick analysis, options appear to be significantly mispriced and do not currently represent potential upside based on historic valuation benchmarks. 

    In January 2009, prior
    to results on AppyScore (which were ultimately viewed unfavorably by the market causing the shares to plummet), the market collectively valued APPY at $238 million (= fully diluted shares outstanding of 31.2 million(1) x $7.63 share price(2)).  Let’s assume this represents a base valuation for AppyScore and let’s also assume that the value of this technology has not changed substantially since January 2009.  If we take the $238 million value and divide by today’s fully diluted shares outstanding of 37.5 million(3), we get a price per share of $6.34.  Options are currently only pricing an upward move of around $0.75~$1.00 from Friday, April 9, 2010’s closing price of $2.33.  If results are positive, the shares should logically trade north of this $6.34 value at the very least (assuming our assumptions are valid).  

    The market is apparently not very confident in the up-and-coming results.  This may represent a very low risk / high reward trade for Call option buyers.  

    (1)  As of December 31, 2008.
    (2)  Closing price as of January 16, 2009.
    (3)  As of March 5, 2010.

    Disclosure: Long APPY Call Options
    Stocks: APPY
Back To Chimera Research Group's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (2)
Track new comments
  • Dan Weiss
    , contributor
    Comments (93) | Send Message
    Im also a fan of the May 2.5 call options which are priced very inexpensive for a major pending event.
    20 Apr 2010, 10:12 PM Reply Like
  • Chimera Research Group
    , contributor
    Comments (385) | Send Message
    Author’s reply » Someone appears to be a very big fan of the June 2.5 Calls based on today's action.
    21 Apr 2010, 06:15 PM Reply Like
Full index of posts »
Latest Followers


  • $CELG $CELG Abraxane ph 3 pancreatic cancer trial shows stat sig improvemnt in overall survival! Suggested this back in June for subscribrs
    Nov 10, 2012
  • We are big believers in $PCYC, $MDVN, $INCY, $SGEN and more.
    Jul 10, 2012
  • $CHTP: 700 call contracts traded today. speculative interest returning...?
    Aug 10, 2010
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.